Great West Life Assurance CO Coherus Bio Sciences, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.59 - $3.85 $92,526 - $224,043	-58,193 Reduced 83.26%	11,699 $39,000
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $157,816 - $229,973	-42,197 Reduced 37.65%	69,892 $261,000
Q2 2023 Aug 10, 2023	BUY	$3.79 - $8.3 $98,342 - $215,368	25,948 Added 30.12%	112,089 $478,000
Q1 2023 May 12, 2023	SELL	$5.89 - $10.52 $16,085 - $28,730	-2,731 Reduced 3.07%	86,141 $590,000
Q4 2022 Feb 10, 2023	BUY	$5.69 - $10.07 $19,607 - $34,701	3,446 Added 4.03%	88,872 $704,000
Q3 2022 Nov 01, 2022	BUY	$7.17 - $13.87 $612,504 - $1.18 Million	85,426 New	85,426 $821,000
Q2 2022 Aug 09, 2022	BUY	$5.86 - $13.23 $50,689 - $114,439	8,650 Added 15.93%	62,935 $456,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $41,358 - $49,677	-2,616 Reduced 4.6%	54,285 $866,000
Q2 2021 Aug 11, 2021	BUY	$12.95 - $15.41 $36,609 - $43,564	2,827 Added 5.23%	56,901 $787,000
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $106,188 - $157,515	-7,364 Reduced 11.99%	54,074 $790,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $99,558 - $113,867	-6,012 Reduced 8.91%	61,438 $1.07 Million
Q3 2020 Nov 17, 2020	BUY	$17.41 - $19.89 $1.14 Million - $1.3 Million	65,416 Added 3216.13%	67,450 $1.24 Million
Q3 2020 Nov 13, 2020	SELL	$17.41 - $19.89 $1.27 Million - $1.45 Million	-72,860 Reduced 97.28%	2,034 $37,000
Q2 2020 Aug 17, 2020	BUY	$14.43 - $19.16 $1.03 Million - $1.37 Million	71,300 Added 1983.86%	74,894 $1.34 Million
Q4 2019 Feb 11, 2020	BUY	$16.33 - $21.37 $58,690 - $76,803	3,594 New	3,594 $64,000
Q3 2019 Oct 25, 2019	SELL	$16.3 - $23.37 $110,416 - $158,308	-6,774 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$13.1 - $22.1 $44,199 - $74,565	3,374 Added 99.24%	6,774 $0
Q3 2017 Nov 09, 2017	BUY	$11.1 - $14.5 $37,740 - $49,300	3,400	3,400 $46,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account